SCHEMBL14083401

SCHEMBL14083401

CCC(C)c1ccc(NC(=O)c2ccc(-c3ncccc3OC)c(Cl)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ TRPV1 Q8NER1 3/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ MAPT P10636 4/20 0.44
▸ THRB P10828 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ NCOR2 Q9Y618 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ GRM4 Q14833 2/20 0.43
▸ P2RX3 P56373 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083319 0.93 ALDH1A1 (0.54) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083384 0.92 TRPV1 (0.55) TP53NPC1SMN1; SMN2RAB9ATRPV1
SCHEMBL14083844 0.91 ALDH1A1 (0.52) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083117 0.90 ALDH1A1 (0.51) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083379 0.87 TRPV1 (0.55) TP53NPC1SMN1; SMN2RAB9ATRPV1
SCHEMBL14083377 0.86 AURKB (0.54) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083374 0.86 MAPT (0.53) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083148 0.85 TRPV1 (0.59) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083306 0.85 TRPV1 (0.58) TP53NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL14083380 0.84 GRM4 (0.61) TP53NPC1SMN1; SMN2ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TP53 4256/4885NPC1 1061/4885SMN1; SMN2 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback